Company news
Skin Elements Ltd. (ASX:SKN) news
Every Skin Elements Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Execution of a Commercialisation Agreement with Farmlands
July 8, 2026
Skin Elements secures $900k Placement
June 25, 2026
SKN - Panel Accepts Undertaking and Declines to Conduct
June 1, 2026
SKN - Panel Receives Application
May 25, 2026
Section 249D Notice Fourth Notice
April 24, 2026
Notice of Extraordinary General Meeting/Proxy Form
April 22, 2026
Section 249D Notice
April 2, 2026
Interim HY Financial Report & Appendix 4D
February 27, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
Two-tranche placement for $2.5 million
October 14, 2025
Trading Halt
October 12, 2025
Preliminary Final Report & Appendix 4E
August 29, 2025
Half Yearly Report and Accounts
February 28, 2025
Entitlement issue Prospectus
December 19, 2024
ENTITLEMENT ISSUE & COURT ORDERS FOR AUDITOR APPOINTMENT
December 19, 2024
Research & Development Rebate
October 1, 2024
Reinstatement to Official Quotation
March 1, 2024
Suspension from Quotation
February 29, 2024
Interim financial report and Appendix 4D
February 29, 2024
R&D tax rebate received and Placement
October 23, 2023
Appendix 4E & Preliminary Final Report
August 31, 2023
Quarterly Activity Report Update - Period ending 30 Jun 23
August 30, 2023
Appendix 4C June quarter amendment
August 10, 2023
Prospectus - non-renounceable pro rata entitlement offer
April 5, 2023
Interim Financial Report & Appendix 4D
February 28, 2023
SKN Raising up to $1.5 million
October 25, 2022
Response to ASX Price Query
September 19, 2022
Preliminary Final Report
August 31, 2022
Skin Elements : Update - Proposed issue of securities - SKN
April 13, 2022
First $1.1 million SuprCuvr Order Delivered
March 15, 2022
Half Year Accounts
February 28, 2022
SKN SuprCuvr Distribution Agreement
January 17, 2022
Pause in Trading
January 17, 2022
Placement
August 31, 2021
SKN secures TGA registration for Invisi Shield SuprCuvr
August 31, 2021
SKN issues Collateral Shares to LDA Capital
May 18, 2021
Appendix 4C - quarterly
April 23, 2021
SKN secures $20 million funding facility
April 6, 2021
SKN Capital Raising Update
April 6, 2021
voluntary suspension extension
March 9, 2021
Quarterly Activities and Appendix 4C Cashflow Report
February 1, 2021
Suspension from Official Quotation
January 27, 2021
Option Underwriting Shortfall and Appendix 2A
January 25, 2021
Response to ASX Price and Volume Query
January 18, 2021
Distribution Agreement Signed for Natural Skincare Range
December 20, 2020
Underwriter Advances $500,000
December 8, 2020
Exclusive Option To Acquire Strategic Stake In Beach Toes
December 8, 2020
TGA Submission for Hospital Grade Invisi Shield Disinfectant
November 10, 2020
Response to ASX Query Letter
October 22, 2020
Update on Termination of Agreement
October 18, 2020